ALFA FinderBSE filing, NSE: FISCHER. Summary written from the filing by ALFA Finder's alert engine.
Fischer Medical Ventures Ltd: key numbers
- Share price
- ₹24.30
- Market cap
- ₹1,683 Cr
- Revenue (annual)
- ₹308.6 Cr
- Net profit (annual)
- ₹31.02 Cr
- P/E (TTM)
- 56.5×Sector 28.2×
- Promoter holding
- 63.08%+0.93% QoQ
- FII holding
- 6.71%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fischer Medical Ventures Ltd
All →Fischer Medical Ventures Management Change
Fischer Medical Ventures appointed Mr. Chan Sing En as Independent Director of SG subsidiary FMV Global Innovations, effective 27 Oct 2026. No financial consideration involved.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures Ltd filed its quarterly shareholding pattern under Regulation 31. This routine disclosure presents the company's current ownership structure.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Ltd has issued a Postal Ballot Notice seeking shareholder approval for creating security on subsidiary assets and promoter share pledges for proposed NCD issuance.
Fischer Medical Ventures Board Meeting Outcome
Fischer Medical Ventures' board approved a postal ballot notice for RPT consent and borrowing limits, and appointed a scrutinizer. No material transaction or financial figure was decided at this meeting.
Fischer Medical Ventures Annual General Meeting
Fischer Medical Ventures Limited conducted its 33rd Annual General Meeting via video conferencing on September 29, 2026, with the requisite quorum present.
Fischer Medical Ventures Other Announcement
Fischer Medical Ventures' subsidiaries declared dividends totaling ₹26.95 Crore. This update provides financial information regarding subsidiary cash flows to the exchange.
- Value
- ₹26.95 Cr
Other capital structure change announcements
All →Tata Steel Capital Structure Change
Tata Steel's stake in subsidiary CPDPL rose from 51% to 57.5% via conversion of preference shares. CPDPL remains a subsidiary; no fresh capital was subscribed.
Filatex India Capital Structure Change
Filatex India invested Rs.13.00 Crore by subscribing 1.30 crore rights shares of wholly owned subsidiary Ecosis at Rs.10. Funds support the polyester recycling project, loan repayment and working capital.
- Value
- ₹13.00 Cr
Zydus Lifesciences Capital Structure Change
LIC sold 20,242,068 Zydus Lifesciences shares via market sale, cutting its stake from 5.21 percent to 3.18 percent. Non-promoter SAST disclosure covering 28.08.2025 to 05.11.2026.
Indian Oil Corporation Capital Structure Change
LIC, a non-promoter shareholder, reported a market sale of 28,34,86,368 shares in Indian Oil, cutting its holding from 7.887% to 5.879%. No monetary value is stated.
- Promoter stake change
- -2.01%
Kirloskar Oil Engines Capital Structure Change
Kirloskar Oil Engines signed a shareholders' agreement with TPG for its subsidiary Arka Fincap. TPG's investment totals ₹800 Crore across two tranches, the second conditional.
- Value
- ₹800.0 Cr
Ace Software Exports Ltd Partly Paidup Capital Structure Change
Ace Software Exports approved a ₹30.25 second and final call on 54,71,101 partly paid shares. The record date is 20 November 2026.
- Value
- ₹16.55 Cr